glp-1 87 kg journey Frontiers GLP-1-based therapies for type 2

Maximum dose: 15 mg subcutaneously once a week

Resistance Band Row (23 sets, 612 reps) Counteracts the forward posture many patients develop during rapid weight loss and strengthens the back muscles critical for spinal support

GLP-1 microdosing is a low-dose treatment approach that uses semaglutide or tirzepatide in smaller, carefully guided amounts

However, a small sample found that Lira did not significantly change levels of the hepatic fat oxidation marker -hydroxybutyrate, although it reduced liver fat [68]

Most hepatic benefits correlate with the degree of weight loss achieved rather than direct liver receptor effects